HealthCare Global Enterprises Ltd (HCG), which listed on the stock exchanges earlier this year, is looking to open more cancer-care centres in the western, northern and eastern regions of the country and also plans to enter the northeast, says chairman BS Ajaikumar.
In an interview with VCCircle, Ajaikumar says there is a large market opportunity for cancer care in India where the WHO predicts 3 million new cancer cases will emerge by 2020.
He also explains why the entry of PE-backed oncology firms doesn’t worry him and why he thinks HCG will maintain its market dominance. “There are no comparable competitors in the Asian market although there are in regions with multispecialty hospitals, trust hospitals and government hospitals,” he says.
Like this video? Sign up for our daily newsletter to get our top reports & videos.
Leave Your Comment
5 years ago
Dr BS Ajaikumar, a practicing oncologist from US-based MD Anderson Cancer, ...
11 months ago
Oncology chain HealthCare Global Enterprises Ltd (HCG) was the only firm in the...
5 years ago
Singapore’s sovereign wealth fund Temasek has invested Rs 140 crore ($25.7...